chitosan has been researched along with myricetin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, L; Li, F; Tang, XJ; Wang, G; Wang, JJ | 1 |
| Ji, G; Li, G; Meng, Q; Shen, H; Wang, H; Xia, M; Xie, Y; Yao, Y | 1 |
| Dasgupta, S; Ghatak, K; Ghosh, P; Parveen, S; Roy, P | 1 |
| Ataullakhanov, FI; Guan, X; Han, Q; Ke, Y; Liu, L; Ma, Z; Meng, W; Panteleev, M; Shi, Q; Xia, Y; Xiang, Z; Ye, H; Zhang, T | 1 |
| Bharti, K; Hosur, RV; Jha, A; Jha, AK; Kumar, A; Mali, PS; Mishra, B; Upadhyay, M | 1 |
| Guo, J; Li, X; Lv, A; Sun, E; Wang, K; Wang, L; Wu, J; Zhang, X; Zhu, Y | 1 |
6 other study(ies) available for chitosan and myricetin
| Article | Year |
|---|---|
In vitro and in vivo evaluation of functionalized chitosan-Pluronic micelles loaded with myricetin on glioblastoma cancer.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Flavonoids; Glioblastoma; Mice; Micelles; Poloxamer; Tissue Distribution | 2016 |
Preparation and evaluation of chitosan-based nanogels/gels for oral delivery of myricetin.
Topics: Administration, Oral; Animals; Biological Availability; Caco-2 Cells; Cell Survival; Chitosan; Drug Compounding; Drug Liberation; Flavonoids; Gels; Glycerophosphates; Humans; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Rats, Sprague-Dawley; Rheology | 2016 |
Flavonoid loaded nanoparticles as an effective measure to combat oxidative stress in Ribonuclease A.
Topics: Antioxidants; Chitosan; Escherichia coli; Flavonoids; Molecular Docking Simulation; Nanoparticles; Oxidants; Oxidation-Reduction; Oxidative Stress; Polyphenols; Quercetin; Ribonuclease, Pancreatic; Tyrosine | 2019 |
Phenylboronic Ester-Bridged Chitosan/Myricetin Nanomicelle for Penetrating the Endothelial Barrier and Regulating Macrophage Polarization and Inflammation against Ischemic Diseases.
Topics: Antioxidants; Chitosan; Endothelium; Humans; Inflammation; Ischemia; Macrophages; Reactive Oxygen Species; Reperfusion Injury | 2023 |
Myricetin encapsulated chitosan nanoformulation for management of type 2 diabetes: Preparation, optimization, characterization and in vivo activity.
Topics: Animals; Chitosan; Diabetes Mellitus, Type 2; Flavonoids; Nanoparticles; Rats; Rats, Wistar | 2023 |
Antimicrobial films fabricated with myricetin nanoparticles and chitosan derivation microgels for killing pathogenic bacteria in drinking water.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Chitosan; Drinking Water; Escherichia coli; Humans; Methicillin-Resistant Staphylococcus aureus; Microgels; Nanoparticles; Staphylococcus aureus; Tannins | 2023 |